Showing results (1-10 of 1,723) with videos related to
Sort By:
Pageof 173
Oncoscience|May 13, 2022
A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 useLong Jiang, Fredrik WermelingCell Reports|October 31, 2019
Neutrophil Recruitment to Noninvasive MRSA at the Stratum Corneum of Human Skin Mediates Transient ColonizationAnette Schulz, Long Jiang, Lisanne de Vor, et al.Computational and Structural Biotechnology Journal|November 8, 2021
A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic systemYunbing Shen, Long Jiang, Vaishnavi Srinivasan Iyer, et al.Bioinformatics (Oxford, England)|April 18, 2017
Green listed-a CRISPR screen toolSudeepta Kumar Panda, Sanjay V Boddul, Guillermina Yanek Jiménez-Andrade, et al.Computational and Structural Biotechnology Journal|September 21, 2020
Designing custom CRISPR libraries for hypothesis-driven drug target discoveryVaishnavi Srinivasan Iyer, Long Jiang, Yunbing Shen, et al.Frontiers in Immunology|November 9, 2017
A Role for the Transcription Factor Arid3a in Mouse B2 Lymphocyte Expansion and Peritoneal B1a GenerationKatrin Habir, Shahin Aeinehband, Fredrik Wermeling, et al.Annals of the New York Academy of Sciences|February 1, 2012
Novel roles for the IgG Fc glycanRobert M Anthony, Fredrik Wermeling, Jeffrey V RavetchCancer Research|November 9, 2021
CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based TherapiesLong Jiang, Katrine Ingelshed, Yunbing Shen, et al.Autoimmunity Reviews|March 14, 2009
An anatomical view on macrophages in toleranceFredrik Wermeling, Mikael C I Karlsson, Tracy L McGahaIscience|May 24, 2024
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumorsKatrine Ingelshed, Marit M Melssen, Pavitra Kannan, et al.Pageof 173